MedTrace Logo

Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics

NCT00870012 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-02-24

No results posted yet for this study

Summary

The investigators' aim is to determine whether probiotic and prebiotic treatment plus lifestyle advice is more effective in reducing hepatic fat content than lifestyle advice alone in patients with Nonalcoholic Fatty Liver Disease (NAFLD).

Conditions

  • Nonalcoholic Fatty Liver Disease

Interventions

DRUG

Lepicol probiotic & prebiotic formula

NAFLD patients treated with Lepicol probiotic and prebiotic formula for 24 weeks.

OTHER

Simple lifestyle advice

NAFLD patients treated with lifestyle advice.

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00870012 on ClinicalTrials.gov